Outsourcing Trends in Pharma & Biotech eBook


Pharma IQ
05/29/2018

Download Your Copy

We respect your privacy, by clicking "Download Your Copy" you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. You have the right to object . In addition, you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. For further information on how we process and monitor your personal data click here. You can unsubscribe at any time.

Outsourcing has been labelled as one of this century’s “greatest organizational and industry structure shifts”.

Pharma’s crutch

The general model in the pharmaceutical and biotechnology industries sees market authorization holders (MAH) rely on external partners to execute a range of activities including the likes of research, development and manufacturing.

Rising pressure from the public regarding medicine price points compounds the appeal of outsourcing as a route to cool costs and free up internal resource burdens.

But, as pharma continues to wrestle with stagnant innovation levels and high failure rates, despite the boost in funds poured into R&D pipelines, cheaper running costs are no longer the primary goal. 

Download this eBook to discover the key outsourcing trends impacting today's pharma and biotech industries. 

RECOMMENDED